Strength and duration of GIPC-dependent signaling networks as determinants in cancer.

Ahmed, Tasmia; Mythreye, Karthikeyan; Lee, Nam Y

Ahmed, Tasmia; Mythreye, Karthikeyan; Lee, Nam Y.

Affiliation

Ahmed T; Deparment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Mythreye K; Division of Molecular and Cellular Pathology, University of Alabama Birmingham, Birmingham, AL, USA.
Lee NY; Deparment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA; Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ, USA; The University of Arizona Cancer Center, Tucson, AZ, USA. Electronic address: namlee@email.arizona.edu.

Neoplasia ; 23(2): 181-188, 2021 02.

Article in En | MEDLINE | ID: mdl-33360508

Subject(s)

Adaptor Proteins, Signal Transducing/metabolism; Carrier Proteins/metabolism; Neoplasms/etiology; Neoplasms/metabolism; Signal Transduction; Animals; Biomarkers; Cell Line, Tumor; Disease Susceptibility; Humans; Neoplasms/pathology; Neuropilins/metabolism; Protein Binding; Protein Transport; Proto-Oncogene Proteins c-akt/metabolism; Receptor, IGF Type 1/metabolism

Key words

Cancer; GIPC signal transduction

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Carrier Proteins / Adaptor Proteins, Signal Transducing / Neoplasms Limits: Animals / Humans Language: En Journal: Neoplasia Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google